The Therapeutic Goods Administration allowed therapeutic use of two psychedelic drugs for specific mental health conditions. Since then, only two cases of psychedelic drug prescriptions have been confirmed. Psilocybin clinical trials are rolling out in Australia, but the Royal College of Psychiatrists has concerns about patients’ elevated expectations. The use of these drugs is only allowed under strict conditions.
Read the full story here
Written by: Peter McCutcheon
Published on February 20, 2024 at 05:51PM
Source: Just In (opens in new tab)